Protective effect of pravastatin on lipopolysaccharide-induced acute lung injury during neutropenia recovery in mice

Experimental Lung Research

Volumn 39, Issue 2, 2013, Pages 99-106

  Yeo, Chang Dong ^a   Rhee, Chin Kook ^a   Kim, In Kyoung ^a   Kang, Hyeon Hui ^a   Lee, Sang Haak ^a   Lee, Sook Young ^a   Kwon, Soon Seok ^a   Kim, Young Kyoon ^a   Kim, Kwan Hyoung ^a   Kim, Jin Woo ^a  

^a Uijeongbu St Mary's Hospital   (South Korea)

Author keywords

Acute lung injury; Matrix metalloproteinase 9; Neutropenia recovery; Nuclear factor kappa B; Pravastatin

Indexed keywords

CYCLOPHOSPHAMIDE; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; PRAVASTATIN; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL AGGREGATION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; LUNG EDEMA; LUNG LAVAGE; MOUSE; NEUTROPENIA; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACUTE LUNG INJURY; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CYCLOPHOSPHAMIDE; DISEASE MODELS, ANIMAL; FEMALE; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED ICR; NEUTROPENIA; NF-KAPPA B; PRAVASTATIN; PULMONARY EDEMA; RESPIRATORY DISTRESS SYNDROME, ADULT; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84874050427     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.3109/01902148.2013.763388     Document Type: Article

References (29)

1. Azoulay E, Darmon M, Delclaux C, Fieux F, Bornstain C, Moreau D, Attalah H, Le Gall JR, Schlemmer B: Deterioration of previous acute lung injury during neutropenia recovery. Crit Care Med. 2002;30:781-786.
2. Azoulay E, Darmon M: Acute respiratory distress syndrome during neutropenia recovery. Crit Care. 2010;14:114.
3. Rhee CK, Kang JY, Kim YH, Kim JW, Yoon HK, Kim SC, Kwon SS, Kim YK, Kim KH, Moon HS, Park SH, Kim HJ, Lee S, Song JS: Risk factors for acute respiratory distress syndrome during neutropenia recovery in patients with hematologic malignancies. Crit Care. 2009;13:R173.
4. Rinaldo JE, Borovetz H: Deterioration of oxygenation and abnormal lung microvascular permeability during resolution of leukopenia in patients with diffuse lung injury. Am Rev Respir Dis. 1985;131:579-583.
5. Chalmers JD, Short PM,Mandal P, Akram AR, Hill AT: Statins in community acquired pneumonia: Evidence from experimental and clinical studies. Respir Med. 2010;104:1081-1091.
6. Chopra V, Flanders SA: Does statin use improve pneumonia outcomes? Chest. 2009;136:1381-1388.
7. Kim JW, Rhee CK, Kim TJ, Kim YH, Lee SH, Yoon HK, Kim SC, Lee SY, Kwon SS, Kim KH, Kim YK: Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis. Clin Exp Pharmacol Physiol. 2010;37:1055-1063.
8. Jacobson JR, Barnard JW, Grigoryev DN, Ma SF, Tuder RM, Garcia JG: Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury. AmJ Physiol LungCell Mol Physiol. 2005;288:L1026-L1032.
9. Yao HW, Mao LG, Zhu JP: Protective effects of pravastatin in murine lipopolysaccharide-induced acute lung injury. Clin Exp Pharmacol Physiol. 2006;33:793-797.
10. Fessler MB, Young SK, Jeyaseelan S, Lieber JG, Arndt PG, Nick JA, Worthen GS: A role for hydroxy-methylglutaryl coenzyme a reductase in pulmonary inflammation and host defense. Am J Respir Crit Care Med. 2005;171:606-615.
11. Craig TR, Duffy MJ, Shyamsundar M, McDowell C, O'Kane CM, Elborn JS, McAuley DF: A randomized clinical trial of hydroxymethylglutaryl-coenzyme a reductase inhibition for acute lung injury (The HARP Study). Am J Respir Crit Care Med. 2011;183:620-626.
12. Luo Y, Zhang B, Xu DQ, Liu Y, Dong MQ, Zhao PT, Li ZC: Protective effect of bicyclol on lipopolysaccharide-induced acute lung injury in mice. Pulm Pharmacol Ther. 2011;24: 240-246.
13. Yang R, Yang L, Shen X, Cheng W, Zhao B, Ali KH, Qian Z, Ji H: Suppression of NF-kappaB pathway by crocetin contributes to attenuation of lipopolysaccharide-induced acute lung injury in mice. Eur J Pharmacol. 2012;674:391-396.
14. Shyamsundar M, McKeown ST, O'Kane CM, Craig TR, Brown V, Thickett DR, Matthay MA, Taggart CC, Backman JT, Elborn JS, McAuley DF: Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers. Am J Respir Crit Care Med. 2009;179:1107-1114.
15. Sachdeva RC, Guntupalli KK: Acute respiratory distress syndrome. Crit Care Clin. 1997;13:503-521.
16. Mokart D, van Craenenbroeck T, Lambert J, Textoris J, Brun JP, Sannini A, Chow-Chine L, Hamouda S, Fouche L, Ettori F, FaucherM, Blache JL: Prognosis of acute respiratory distress syndrome (ARDS) in neutropenic cancer patients. Eur Respir J. 2012;40:169-176.
17. Hirsh M, Carmel J, Kaplan V, Livne E, Krausz MM: Activity of lung neutrophils and matrix metalloproteinases in cyclophosphamide-treated mice with experimental sepsis. Int J Exp Pathol. 2004;85:147-157.
18. Reutershan J, Basit A, Galkina EV, Ley K: Sequential recruitment of neutrophils into lung and bronchoalveolar lavage fluid in LPS-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2005;289:L807-L815.
19. van Eeden SF, Kitagawa Y, Sato Y, Hogg JC: Polymorphonuclear leukocytes released from the bone marrow and acute lung injury. Chest. 1999;116:43S-46S.
20. Wang CY, Liu PY, Liao JK: Pleiotropic effects of statin therapy: molecular mechanisms and clinical results. Trends Mol Med. 2008;14:37-44.
21. Terblanche M, Almog Y, Rosenson RS, Smith TS, Hackam DG: Statins and sepsis: multiple modifications at multiple levels. Lancet Infect Dis. 2007;7:358-368.
22. Bellosta S, Via D, Canavesi M, Pfister P, Fumagalli R, Paoletti R, Bernini F: HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages. Arterioscler Thromb Vasc Biol. 1998;18:1671-1678.
23. Chello M, Anselmi A, Spadaccio C, Patti G, Goffredo C, Di Sciascio G, Covino E: Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery. Ann Thorac Surg. 2007;83:1374-1380.
24. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334-1349.
25. Lu YC, Yeh WC, Ohashi PS: LPS/TLR4 signal transduction pathway. Cytokine. 2008;42:145-151.
26. Imai Y, Kuba K, Neely GG, Yaghubian-Malhami R, Perkmann T, van Loo G, Ermolaeva M, Veldhuizen R, Leung YH, Wang H, Liu H, Sun Y, Pasparakis M, Kopf M, Mech C, Bavari S, Peiris JS, Slutsky AS, Akira S, Hultqvist M, Holmdahl R, Nicholls J, Jiang C, Binder CJ, Penninger JM: Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell. 2008;133:235-249.
27. Gibbs DF, Shanley TP, Warner RL, Murphy HS, Varani J, Johnson KJ: Role of matrix metalloproteinases in models of macrophage-dependent acute lung injury. Evidence for alveolar macrophage as source of proteinases. Am J Respir Cell Mol Biol. 1999;20:1145-1154.
28. Kang JL, Lee HW, Lee HS, Pack IS, Castranova V, Koh Y: Time course for inhibition of lipopolysaccharide-induced lung injury by genistein: relationship to alteration in nuclear factor-kappaB activity and inflammatory agents. Crit Care Med. 2003;31:517-524.
29. Dooley JL, Abdel-Latif D, St Laurent CD, Puttagunta L, Befus D, Lacy P: Regulation of inflammation by Rac2 in immune complex-mediated acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2009;297:L1091-1102.